MedCity News » Diabetes

This week at HLTH, Dexcom COO Jake Leach discussed Stelo, his company’s new product. Stelo is an over-the-counter continuous glucose monitor meant for all adults who don’t take insulin. ...

https://medcitynews.com/2024/10/dexcom-diabetes-healthcare/

Continuous Glucose Monitoring tools are revolutionizing the way diabetes is managed, offering unparalleled benefits for both healthcare providers and patients. By providing continuous, accura...

https://medcitynews.com/2024/09/improved-access-to-cgm-data-empowers-providers-and-patients-to-more-effectively-partner-on-diabetes-management/

Over the past decade, Abbott and Dexcom — the two largest makers of continuous glucose monitors — have been teaming up with medical device companies that sell automated insulin delivery s...

https://medcitynews.com/2024/08/diabetes-healthcare-medical-device/

The FDA rejected Novo Nordisk’s biologics license application for icodec, citing questions about the manufacturing process for this once weekly insulin as well as its use by type 1 diabetes...

https://medcitynews.com/2024/07/fda-novo-nordisk-diabetes-basal-insulin-icodec/

Abbott recently launched the FreeStyle Libre 3 Plus sensor, which it says is the smallest and most discreet sensor on the market. It will soon be available in U.S. retail pharmacies and medic...

https://medcitynews.com/2024/07/abbott-diabetes-cgm/

No one should ever learn about CKD after their kidneys have already failed. The post One Conversation Could Be All It Takes to Identify Chronic Kidney Disease appeared first on MedCity New...

https://medcitynews.com/2024/07/one-conversation-could-be-all-it-takes-to-identify-chronic-kidney-disease/

Novo Nordisk’s focus on diabetes and obesity shape its business development work, but the company is also exploring other areas. Top Novo Nordisk M&A executive John McDonald discussed his c...

https://medcitynews.com/2024/06/at-bio-novo-nordisks-top-dealmaker-talks-ma-strategy-and-whats-next-after-glp-1s/

By working together to build an ecosystem of support around people with diabetes, the healthcare system as a whole can ensure that no one slips through the cracks. The post As Interest in G...

https://medcitynews.com/2024/06/as-interest-in-glp-1s-explodes-people-living-with-diabetes-need-structured-support-to-ensure-effective-use/

Johns Hopkins Hospital teamed up with Healthy.io, a company that offers smartphone-based technology to improve wound care management for diabetic patients. The partners are conducting a 120-p...

https://medcitynews.com/2024/04/ai-diabetes-healthcare/

Biolinq raked in $58 million in capital this week. The company is developing a wearable patch that uses electrochemical sensors to measure a person’s glucose levels from the intradermal spa...

https://medcitynews.com/2024/04/diabetes-cgm-healthcare-biosensor/

A new report from the Peterson Health Technology Institute analyzed eight digital diabetes management tools. It found that the tools don’t provide meaningful clinical benefits and increase ...

https://medcitynews.com/2024/03/digital-diabetes-management-tools/

Valendo Health, the newest startup built at Redesign Health, launched on Tuesday. The company partners with independent endocrinology practices and provides technology to help them thrive in ...

https://medcitynews.com/2024/01/vbc-diabetes-endocrinology-startup/

Insulin prices have long been a pain point for diabetics. The big three insulin manufacturers have cut prices across their product lineups, but potential competition from other biosimilar ins...

https://medcitynews.com/2024/01/biosimilar-insulin-diabetes-biologic-drugs/

New research found that there are no racial disparities in weight loss results among patients taking obesity drugs. However, the study found that people of color have less access to services ...

https://medcitynews.com/2024/01/obesity-drugs-medication-weight-loss/

Amazon launched a new initiative to help connect people to digital health benefits that they may not know are available to them. Omada Health is its first partner. CEO Sean Duffy said his com...

https://medcitynews.com/2024/01/amazon-diabetes-omada-jpm/

Geoff Martha sought to establish a clear line between popular understanding of AI created by apps like ChatGPT and what he believes is the significant impact that Medtronic’s AI-enabled pro...

https://medcitynews.com/2024/01/medtronic-ceo-chatgpt/

Twin Health raked in $50 million in Series D financing. The startup seeks to help patients improve their metabolic health and reduce the need for medications through the “digital twin” te...

https://medcitynews.com/2023/12/obesity-healthcare-diabetes/

A new guide from Northeast Business Group on Health helps employers understand the challenges women face when it comes to cardiovascular disease, diabetes and obesity. It also recommends acti...

https://medcitynews.com/2023/12/employers-women-cardiovascular-disease/

Roche’s Carmot Therapeutics acquisition brings three clinical-stage assets that the companies say could be best-in-class drugs for metabolic disorders. In addition to standalone use, Roche ...

https://medcitynews.com/2023/12/roche-acquisition-obesity-diabetes-metabolic-disorder-carmot-therapeutics/

The German manufacturing site is the latest capital infrastructure move for Eli Lilly, which has already made $11 billion in investments in its global manufacturing capabilities in the past t...

https://medcitynews.com/2023/11/eli-lilly-plans-new-2-5b-manufacturing-site-in-germany-for-injectable-meds/

AstraZeneca gains global rights to an oral GLP-1 agonist on track to reach Phase 2 testing in 2024. Under China-based Eccogene, the small molecule’s Phase 1 data show reductions in glucose ...

https://medcitynews.com/2023/11/astrazeneca-glp1-obesity-cardiometabolic-eccogene/

Walgreens is seeing “an enormous amount of demand” for injectable weight loss drugs, its president of U.S. healthcare said during the Reuters Total Health conference in Chicago. He declar...

https://medcitynews.com/2023/11/walgreens-glp-1-reimbursement-healthcare-obesity/

Eli Lilly weight management drug Zepbound landed its much anticipated FDA approval. The new Lilly product is in the same drug class as Novo Nordisk weight medication Wegovy, but it offers an ...

https://medcitynews.com/2023/11/fda-approval-eli-lilly-weight-loss-obesity-zepbound/

This week, Abbott announced its plans to acquire Bigfoot Biomedical — a startup selling a “smart” insulin pen cap, which collects data from a user’s CGM to help them calculate the rig...

https://medcitynews.com/2023/09/abbott-diabetes-acquisition/

As the U.S. healthcare system works to focus on the move to preventive, personalized care for patients, it’s time to turn the tide on diabetes by addressing the three Cs of chronic disease ...

https://medcitynews.com/2023/08/prioritizing-sdoh-for-patients-living-with-chronic-diseases-compassion-coordination-and-community/

Amazon Pharmacy announced Tuesday that it is launching automatic coupons for more than 15 insulin and diabetes care brands. The move, while incremental, solves a major pain point for consumer...

https://medcitynews.com/2023/08/amazon-pharmacy-coupons-diabetes-insulin-prescription-drugs/

Social media should play a bigger part in public health crisis planning, according to a recent analysis. The analysis explored the crucial role that Twitter and other social media platforms p...

https://medcitynews.com/2023/07/abbott-diabetes-social-media-twitter/

Oura — a company selling a ring that tracks peoples’ biometrics — announced new partnerships with three providers of continuous glucose monitors: January, Supersapiens and Veri. These c...

https://medcitynews.com/2023/06/oura-sleep-cgm-wearables/

Know Labs recently unveiled the prototype for its non-invasive, portable glucose monitoring device. The device incorporates the company’s proprietary body-radio frequency identification (Bi...

https://medcitynews.com/2023/06/diabetes-medical-device-blood-glucosse-monitoring-healthcare/

With obesity, diabetes, and heart disease rapidly growing among communities of color, we need to do everything we can to help people sustain healthy eating habits. It’ll take more nuance th...

https://medcitynews.com/2023/05/is-it-possible-to-provide-equitable-nutritional-care-for-diabetes-and-obesity/